Impact of anti-Tumour Necrosis Factor (Anti-TNF) Biological Therapy on Insulin Sensitivity in Patients with Crohn's Disease: A Literature Review
DOI:
https://doi.org/10.33448/rsd-v13i2.45052Keywords:
Inflammatory bowel disease; Biological therapy; Anti-TNF therapy; Insulin resistance; Crohn's disease.Abstract
Introduction: Crohn's disease is an inflammatory bowel disease that affects any part of the gastrointestinal tract, from the mouth to the anus, resulting in an exacerbated inflammatory process. Medication-based approaches have been effective in symptom control, and among them, biological therapy serves as an ally in maintaining patient remission. Objective: To report the action of anti-TNF biological treatment on insulin profiles in patients with Crohn's disease, considering that insulin sensitivity is impaired by the high expression of TNF-alpha in the disease. Methods: A narrative review was conducted, collecting articles from the last 10 years to seek current scientific evidence on the topic. Six steps were followed for this review, utilizing the following databases: Google Scholar, LILACS, National Library of Medicine (PubMed), and SciELO. The final number of articles was determined through a thematic similarity analysis, considering the research objective. Results: After the searches, 125 articles were identified, but only 55 articles were selected for analysis and discussion. The literature review demonstrates that insulin resistance may be higher in obese patients at risk of developing type 2 diabetes. Conclusion: In summary, it is shown that there is a relationship between metabolic diseases and inflammatory bowel disease, and anti-TNF biological therapy may be effective in both situations.
References
Adamina, M., Bonovas, S. Raine, T., et al. (2008). ECCO guidelines on Therapeutics in Crohn’s Disease: Surgical Tratament. Journal of Crohn’s and Colits, 14(2), 155–168. doi.org/10.1093/ecco-jcc/jjz187.
Adegbola, O., S. Sahnan, K. Warusavitarne, J., Hart, A. & Tozer, P. (2018). Anti-TNF therapy in Crohn's disease. Int. J. Mol. Ciência. 19, 2244. doi:10.3390/ijms19082244.
Agrawal, M., Allin, K. H., Petralia, F., et al. (2022). Multiomics to elucidate inflammatory bowel disease risk factors and pathways. Nature Review Gastroenterol Hepatol 19, 399–409. doi.org/10.1038/s41575-022-00593-y.
Ahmed, W., Galati, J., Kumar, A., et al. (2022). Dual Biologic or Small Molecule Therapy for treatment of inflammatory Bowel Disease: A Systematic Review and meta-analysis. Clinical Gastroenterology and Hepatology 20(3). doi.org/10.1016/j.cgh.2021.03.034.
Albuquerque, C, I., Meinicke, T, P., & Maciel, B, N. (2018). Doença de Crohn Perianal: Qual é a importância das cirurgias programadas associadas a terapia com imunobiológicos para remissão completa? Journal of Coloproctology. 38(1), 139.
Almeida, D. S. G. & Ferraza. R. (2023). Diagnóstico tardio de Doença de Crohn Fibroestenosante-Fistulizante: relato de caso. Revista Eletrônica Acervo Saúde, 23(3), e12519. doi.org/10.25248/reas.e12519.2023.
Amiot, A., Bouguen, G., & Bonnaud, G. (2020). Clinical guidelines for the management of inflammatory bowel disease: Update of a Franch national consensus. Digestive and Liver Disease, mg5, November 4.
Baeta, M, O., Alves, K, A., & Moreno, M, J. (2023). Crohn's disease - a comprehensive review of epidemiology, pathophysiology and pathogenesis, risk factors, clinical diagnosis, imaging diagnosis, extraintestinal manifestations, treatment, nutrition and diet. Brazilian Journal of Health Review, 6(4), 17438-17454.
Basílio, S. F., Santos, M. J., & Branco, S. C. (2021). The role of oxidative stress in Crphn’s Disease: A narrative review. Research, society and development, 10(4), e52910414445.
Best, R, W., Becktel, M, J., & Singleton, W, J. (1976). Development of a Crohn’s Disease Activity Index. National Cooperative Crohn’s Disease Study. Gastroenterology. 70:439-444, V. 70. No. 3.
Brasil. Ministério da Saúde. (2022). Dia Mundial da Doença Inflamatória Intestinal: “DII não tem idade”. Biblioteca Virtual em Saúde Ministério da Saúde, 2022. https://bvsms.saude.gov.br/19-5-dia-mundial-da-doenca-inflamatoria-intestinal-dii-nao-tem-idade/#footer. Acesso em: 29 ago. 2023.
Brasil. Ministério da Saúde. (2017). Secretaria de Atenção à Saúde. Protocolo Clínico e Diretrizes Terapêuticas da Doença de Crohn. Ministério da Saúde. Pág. 1-56. Portaria Conjunta Nº 14.
Brito, S.G. I., Silva, T. S. C., Bravin, C, B., et al. (2022). The prevalence of Crohn's disease cases in the brazilian population from 2013 to 2017. Brazilian Journal of Development, 8(5), 41656-41670.
Burska, A. N., Sakthiswary R., & Sattar, N. (2015). Effects of tumour necrosis factor antagonists on insulin sensitivity/resistance in rheumatoid arthritis: a systematic review and meta-analysis. PLoS One. V.10, n.6, article e0128889. doi: 10.1371/journal.pone.0128889.
Carvalho, C. L., Silva, S. E., Roma, M. L. A., et al. (2022). Inflammatory bowel diseases: a general approach, REAMed. 2. doi.org/10.25248/REAMed.e9650.2022.
Chang, T, J. (2020). Pathophysiology of Inflammatory Bowel Disease. The New England Journal of Medicine. 383(27):2652-2664.
Davies, A., Nixon, A., Tsintzas, K., et al. (2021). Skeletal muscle anabolic and insulin sensitivity responses to a mixed meal in adult patients with active Crohn's disease. Nutrição Clínica ESPEN 41. p 305e313.
De Acosta, B, M., Molero, A., Artime, E., et al. (2023). Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review. Adv Ther. 40:1975–2014. doi.org/10.1007/s12325-023-02473-6.
Deepak, P. & Gergely, M. (2022). Tools for the Diagnosis and management of Cronh’s Disease. Gastroenterology Clinics os North America. 51(2), 213 -239.
Dogan, N.A., Kahraman, R., & Akar, T. (2022). Assessment of insulin resistance and beta cell activity in patients with inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 26(11), 3989-3994. Doi.org/10.1056/NEJMra2002697.
Feitosa Neto, G. da S., & Damasceno, Ia de M. (2023) Doença de Crohn e suas particularidades: uma revisão de literatura. Pesquisa, Sociedade e Desenvolvimento, 5, e26112541923. 10.33448/rsd-v12i5.41923.
Ferreira, S, G., Deus de A, H, M., & Junior, A, E. (2021). Pathophysiology and etiologies of the inflammatory boewl disease: a systematic review. Brazilian Journal of Health Review, 4(4), 17061-17076.
Franco, S. A. C., Marques, P. F. S., & Gomes, V. E. (2023). Crohn's disease: a literature review. Brazilian Journal of Development, 9(1), 3797-3805.
Froes, R. (2019). Atualização em doenças inflamatórias intestinais. Grupo de Estudos da Doença Inflamatória Intestinal no Brasil. Fortaleza. Editora: Office Publicações Científicas Ltda. 19-63.
Gomes, R. J. R. (2022). Doença de Crohn: Abordagem terapêutica atual e perspetivas futuras. Dissertação de Mestrado em Ciências Farmacêuticas. Universidade Do Algarve Faculdade de Ciências e Tecnologia, 92.
Gonzalez -Gay. M. A., Gonzalez-Juanatey, C., Vazquez-Rodriguez, T. et al. (2010). Insulin resistance in rheumatoid arthritis: the impact of the anti-TNF-α therapy. Annals of the New York Academy of Sciences. 1193(1), 153–159. Doi.org/10.1111/j.1749-6632.2009.05287.x.
Graham, B., D., & Xavier, J, R (2020). Pathway Paradigms Revealed from the Genetics of Inflammatory Bowel Diseas, Nature. 578(7796), 527–539. Doi.org/10.1038/s41586-020-2025-2.
Harvey, F, R., Bradshaw, M, J. (1980). A Simple Index of Crohn’s Disease Activity. The Lancet. Methods and Decives, 315(8167), 514.
Hotamisligi, G. S., Peraldj, P., Budaravi A. et al., (1996). IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α- and obesity-induced insulin resistance. Science. 271(5249), 665–670. Doi.org/10.1126/science.271.5249.665.
Korkmaz, H., Sahin, F., Ipecki, H, S. et al., (2014). Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease. European Journal of Gastroenterology & Hepatology. 26(7).
Kotze, G, P., Underwood, E, F., Damião, C, M, O, A. et. al., (2020). Progression of Inflammatory Bowel Diseases Throughout Latin America and The Caribbean: A Systematic Review. Clinical Gastroenteroly and Hepatology. Systematic reviews ans meta-analyses. 18(2), 304-312.
Leal, A, S. (2015). Resposta Inflamatória no Contexto da Doença Inflamatória Intestinal. Monografia em Ciências Farmacêuticas. Universidade de Coimbra, 29.
Leppkesa, M., & Neurath, M. F. (2020). Cytokines in inflammatory bowel diseases. Pharmacological Research Elsevier. 158, 104835.
Lin, D. T. F., Mazarotto, J. E., & Gregório, C. P. (2023). Doença de Crohn: aspectos integrativos do diagnostico ao tratamento. Research, Society and Development. 12(2), e29212240368.
Magro, F., Cordeiro, G., Dias, M. A. et al., (2020). Inflammatory Bowel Disease – Non-biological treatment. Pharmacological Research. 160. 105075.
Mello, J. D. C. (2022). Quimiocinas e adipocinas como marcadores da atividade da doença de Crohn. Dissertação de Mestrado. Universidade Estadual de Campinas Faculdade de Ciências Médicas.
M'koma, E, A. (2022). Inflammatory Bowel Disease: Clinical and Surgical Diagnosis Treatment overview. Medicina MDPI. 58(5), 567.
Mohamadinarab, M., Ahmadi, R; Gholamrezavy, A. et al., (2020). Serum levels of C1q/TNF-related protein-3 in inflammatory bowel disease patients and its inverse association with inflammatory cytokines and insulin resistance. IUBMB Life. 72(8), 1698-1704.
Otte, L, M., Tamang, L, R; Papapanagagiotou, J. et al., (2023). Mucosal healing and inflammatory boewl disease: Therapeutic implications and new targets. World J Gastroenterol. 29(7), 1157-1172. Doi.org/10.3748/wjg.v29.i7.1157.
Park, S. Y., & Gautier, J. F. (2021). Chon S. Assessment of Insulin Secretion and Insulin Resistance in Human. Diabetes Metab J. 45(5), 641-654.
Paschou, A., S., Kothonas, F. Lafkas, A. et al., (2018). Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Non-Obese, Non-Diabetic Patients With Inflammatory Bowel Disease. Hindawi International Journal of Endocrinology. Artigo ID 6712901, 5 páginas doi.org/10.1155/2018/6712901.
Pereira, J, M., Freitas, C, T., Santos, P, V. et al., (2021). Doença de crohn: aspectos fisiopatológicos e exames mais solicitados. Trabalho de conclusão de curso em Biomedicina. Faculdade UNA Pouso Alegre.
Petgana, L., Antonelli, A., Ganini, C. et al., (2020). Pathophysiology of Crohn’s disease inflammation and recurrence. Biology Direct 15, 23. doi.org/10.1186/s13062-020-00280-5.
Roda, G., Chien Ng, S., Kotze, P. G. et al., (2020). Crohn’s Disease. Nature Reviews Disease Primers 6, 22. doi.org/10.1038/s41572-020-0156-2.
Rosalino, R. (2022). Seguimento de pacientes portadores de Doença de Crohn em uso de terapia biológica. Tese de Residência Médica em Coloproctologia. Hospital do servidor público municipal, 27. https://pesquisa.bvsalud.org/portal/resource/pt/biblio-1414277. Acesso em: 18 ago. 2023.
Silva, L, A., & Peixoto, S, M. (2020). Um modelo para determinar a fase da doença de Crohn via sistema fuzzy. IMECC, UNICAMP. 30(2020), 241 -254.
Toscano, B. A., Ferré, M. D., Menacho, M. et al., (2022). Anti TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease. Int. J. Mol. Sci. 23(19), 11170; doi.org/10.3390/ijms231911170.
Vasudevan, A., Bruining, H. D., Junior, L. V. E. et al., (2021). Approach to medical therapy in perianal Crohn’s disease. World J Gastroenterol 27(25), 3693-3704. Doi.org/10.3748/wjg.v27.i25.3693.
Veauthier, B., & Hornecker, R. J. (2028). Crohn’s Disease: Diagnosis and Management. American Family Physician. 98(11).
Verdugo-Meza, A., Ye, J., Dadlani, H. et al., (2020). Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites. Nutrients. 12, 1434. doi.org/10.3390/nu12051434.
Wallace, K. L. (2014). Immunopathology of inflammatory bowel disease. World J Gastroenterol. 20(1), 6. Doi.org/10.3748/wjg.v20.i1.6.
Woldan, M. V. (2022). Inflamável: Pouco estudadas, as doenças inflamatórias intestinais (DII) atingem 13 catarinenses a cada 100 mil habitantes, requerem tratamentos que podem custar centenas de milhares de reais por ano e muitos pacientes ainda são negligenciados. 2021. Trabalho de Conclusão de Curso (Jornalismo) - Univerdade Federal de Santa Catarina, 1-27.
Yoo, Y. J., Groer, M., Dutra, O. V. S. et. al., (2020). Gut Microbiota and Immune System Interactions. PubMed Central. Microrganismos, 8(10), 1587. doi.org/10.3390/microorganisms8101587.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Gabriele Alves de Lima; Amanda Caroline Venturelli; Sergio Ricardo de Brito Bello; Rosana Menezes de Souza; Camila Tedeschi Pazello; Raquel Simone Maccarini Zarpellon; Suelen Gonçalves dos Santos Rodrigues
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
